| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5214052 | SANDOZ | Method for dissolving arginineamides and pharmaceutical compositions containing them |
Jun, 2014
(9 years ago) | |
Argatroban is owned by Sandoz.
Argatroban contains Argatroban.
Argatroban has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Argatroban are:
- US5214052
Argatroban was authorised for market use on 30 June, 2000.
Argatroban is available in injectable;injection dosage forms.
The generics of Argatroban are possible to be released after 30 June, 2014.
Drugs and Companies using ARGATROBAN ingredient
Market Authorisation Date: 30 June, 2000
Treatment: NA
Dosage: INJECTABLE;INJECTION
How can I launch a generic of ARGATROBAN before it's drug patent expiration?
More Information on Dosage
ARGATROBAN family patents
